Evonik Industries AG establishes production of recombinant collagen
Evonik Industries has established a new animal-free and fermentation-based industrial-scale recombinant collagen production platform.
BioNTech SEs COVID-19 vaccine attracts investment
Chinese Fosun Pharma Ltd has made the largest investment in a foreign company for a COVID-19 vaccine development: BioNTechd mRNA vaccine BNT162.
Commission relaunches circular economy action plan
Under its Green Deal, the European Commission has presented a circular (bio)economay action plan that prepares the ground for a sustainable bio-economy.
Roche unravel biomarker for checkpoint blockade
Researchers at Swiss pharma giant Roche AG have found a subpopulation of dendritic cells to determine how cancer patients respond to immune checkpoint inhibitors.
Nutrition influences the course of MS
New data prove that propionic acid modulates the intestine-mediated immune regulation in people with multiple sclerosis (MS).
LSP launches US-$600m European life sciences fund
LSP has closed its LSP 6 fund at the $600m hard cap. It is the largest fund ever raised in Europe focused on life sciences ventures.
Biotalys grabs 45m in Series C financing
Pest control specialist Biotalys NV has raised an additional 10m to its series C financing bringing its amount to 45m.
German and UK researchers cut time to sepsis diagnosis
Researchers from German Fraunhofer IGBI have used next-generation sequencing (NGS) to diagnosis sepsis from tiny amounts of microbial DNA in the blood.
IMI launches 45m call for coronavirus emergency
The Innovative Medicines Initiative (IMI) has announced a 45m funding for the development of therapeutics and diagnostics to tackle coronavirus outbreaks.
Immunocore Ltd raises US$130m in Series B round
With the financing led by General Atlantic, the British company wants to expand a novel platform and advance its ImmTAX pipeline to the clinic.